Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma

J. S. Ried, H. Baurecht, F. Stückler, J. Krumsiek, C. Gieger, J. Heinrich, M. Kabesch, C. Prehn, A. Peters, E. Rodriguez, H. Schulz, K. Strauch, Karsten Suhre, R. Wang-Sattler, H. E. Wichmann, F. J. Theis, T. Illig, J. Adamski, S. Weidinger

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background Genome-wide association studies (GWAS) have identified many risk loci for asthma, but effect sizes are small, and in most cases, the biological mechanisms are unclear. Targeted metabolite quantification that provides information about a whole range of pathways of intermediary metabolism can help to identify biomarkers and investigate disease mechanisms. Combining genetic and metabolic information can aid in characterizing genetic association signals with high resolution. This work aimed to investigate the interrelation of current asthma, candidate asthma risk alleles and a panel of metabolites. Methods We investigated 151 metabolites, quantified by targeted mass spectrometry, in fasting serum of asthmatic and nonasthmatic individuals from the population-based KORA F4 study (N = 2925). In addition, we analysed effects of single-nucleotide polymorphisms (SNPs) at 24 asthma risk loci on these metabolites. Results Increased levels of various phosphatidylcholines and decreased levels of various lyso-phosphatidylcholines were associated with asthma. Likewise, asthma risk alleles from the PDED3 and MED24 genes at the asthma susceptibility locus 17q21 were associated with increased concentrations of various phosphatidylcholines with consistent effect directions. Conclusions Our study demonstrated the potential of metabolomics to infer asthma-related biomarkers by the identification of potentially deregulated phospholipids that associate with asthma and asthma risk alleles.

Original languageEnglish
Pages (from-to)629-636
Number of pages8
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume68
Issue number5
DOIs
Publication statusPublished - May 2013
Externally publishedYes

Fingerprint

Phosphatidylcholines
Asthma
Alleles
Biomarkers
Metabolomics
Genome-Wide Association Study
Single Nucleotide Polymorphism
Fasting
Mass Spectrometry
Phospholipids
Serum

Keywords

  • asthma
  • genetics
  • lipids
  • metabolomics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. / Ried, J. S.; Baurecht, H.; Stückler, F.; Krumsiek, J.; Gieger, C.; Heinrich, J.; Kabesch, M.; Prehn, C.; Peters, A.; Rodriguez, E.; Schulz, H.; Strauch, K.; Suhre, Karsten; Wang-Sattler, R.; Wichmann, H. E.; Theis, F. J.; Illig, T.; Adamski, J.; Weidinger, S.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 68, No. 5, 05.2013, p. 629-636.

Research output: Contribution to journalArticle

Ried, JS, Baurecht, H, Stückler, F, Krumsiek, J, Gieger, C, Heinrich, J, Kabesch, M, Prehn, C, Peters, A, Rodriguez, E, Schulz, H, Strauch, K, Suhre, K, Wang-Sattler, R, Wichmann, HE, Theis, FJ, Illig, T, Adamski, J & Weidinger, S 2013, 'Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma', Allergy: European Journal of Allergy and Clinical Immunology, vol. 68, no. 5, pp. 629-636. https://doi.org/10.1111/all.12110
Ried, J. S. ; Baurecht, H. ; Stückler, F. ; Krumsiek, J. ; Gieger, C. ; Heinrich, J. ; Kabesch, M. ; Prehn, C. ; Peters, A. ; Rodriguez, E. ; Schulz, H. ; Strauch, K. ; Suhre, Karsten ; Wang-Sattler, R. ; Wichmann, H. E. ; Theis, F. J. ; Illig, T. ; Adamski, J. ; Weidinger, S. / Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. In: Allergy: European Journal of Allergy and Clinical Immunology. 2013 ; Vol. 68, No. 5. pp. 629-636.
@article{17e19323d9a94239964e8e6ec9609181,
title = "Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma",
abstract = "Background Genome-wide association studies (GWAS) have identified many risk loci for asthma, but effect sizes are small, and in most cases, the biological mechanisms are unclear. Targeted metabolite quantification that provides information about a whole range of pathways of intermediary metabolism can help to identify biomarkers and investigate disease mechanisms. Combining genetic and metabolic information can aid in characterizing genetic association signals with high resolution. This work aimed to investigate the interrelation of current asthma, candidate asthma risk alleles and a panel of metabolites. Methods We investigated 151 metabolites, quantified by targeted mass spectrometry, in fasting serum of asthmatic and nonasthmatic individuals from the population-based KORA F4 study (N = 2925). In addition, we analysed effects of single-nucleotide polymorphisms (SNPs) at 24 asthma risk loci on these metabolites. Results Increased levels of various phosphatidylcholines and decreased levels of various lyso-phosphatidylcholines were associated with asthma. Likewise, asthma risk alleles from the PDED3 and MED24 genes at the asthma susceptibility locus 17q21 were associated with increased concentrations of various phosphatidylcholines with consistent effect directions. Conclusions Our study demonstrated the potential of metabolomics to infer asthma-related biomarkers by the identification of potentially deregulated phospholipids that associate with asthma and asthma risk alleles.",
keywords = "asthma, genetics, lipids, metabolomics",
author = "Ried, {J. S.} and H. Baurecht and F. St{\"u}ckler and J. Krumsiek and C. Gieger and J. Heinrich and M. Kabesch and C. Prehn and A. Peters and E. Rodriguez and H. Schulz and K. Strauch and Karsten Suhre and R. Wang-Sattler and Wichmann, {H. E.} and Theis, {F. J.} and T. Illig and J. Adamski and S. Weidinger",
year = "2013",
month = "5",
doi = "10.1111/all.12110",
language = "English",
volume = "68",
pages = "629--636",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma

AU - Ried, J. S.

AU - Baurecht, H.

AU - Stückler, F.

AU - Krumsiek, J.

AU - Gieger, C.

AU - Heinrich, J.

AU - Kabesch, M.

AU - Prehn, C.

AU - Peters, A.

AU - Rodriguez, E.

AU - Schulz, H.

AU - Strauch, K.

AU - Suhre, Karsten

AU - Wang-Sattler, R.

AU - Wichmann, H. E.

AU - Theis, F. J.

AU - Illig, T.

AU - Adamski, J.

AU - Weidinger, S.

PY - 2013/5

Y1 - 2013/5

N2 - Background Genome-wide association studies (GWAS) have identified many risk loci for asthma, but effect sizes are small, and in most cases, the biological mechanisms are unclear. Targeted metabolite quantification that provides information about a whole range of pathways of intermediary metabolism can help to identify biomarkers and investigate disease mechanisms. Combining genetic and metabolic information can aid in characterizing genetic association signals with high resolution. This work aimed to investigate the interrelation of current asthma, candidate asthma risk alleles and a panel of metabolites. Methods We investigated 151 metabolites, quantified by targeted mass spectrometry, in fasting serum of asthmatic and nonasthmatic individuals from the population-based KORA F4 study (N = 2925). In addition, we analysed effects of single-nucleotide polymorphisms (SNPs) at 24 asthma risk loci on these metabolites. Results Increased levels of various phosphatidylcholines and decreased levels of various lyso-phosphatidylcholines were associated with asthma. Likewise, asthma risk alleles from the PDED3 and MED24 genes at the asthma susceptibility locus 17q21 were associated with increased concentrations of various phosphatidylcholines with consistent effect directions. Conclusions Our study demonstrated the potential of metabolomics to infer asthma-related biomarkers by the identification of potentially deregulated phospholipids that associate with asthma and asthma risk alleles.

AB - Background Genome-wide association studies (GWAS) have identified many risk loci for asthma, but effect sizes are small, and in most cases, the biological mechanisms are unclear. Targeted metabolite quantification that provides information about a whole range of pathways of intermediary metabolism can help to identify biomarkers and investigate disease mechanisms. Combining genetic and metabolic information can aid in characterizing genetic association signals with high resolution. This work aimed to investigate the interrelation of current asthma, candidate asthma risk alleles and a panel of metabolites. Methods We investigated 151 metabolites, quantified by targeted mass spectrometry, in fasting serum of asthmatic and nonasthmatic individuals from the population-based KORA F4 study (N = 2925). In addition, we analysed effects of single-nucleotide polymorphisms (SNPs) at 24 asthma risk loci on these metabolites. Results Increased levels of various phosphatidylcholines and decreased levels of various lyso-phosphatidylcholines were associated with asthma. Likewise, asthma risk alleles from the PDED3 and MED24 genes at the asthma susceptibility locus 17q21 were associated with increased concentrations of various phosphatidylcholines with consistent effect directions. Conclusions Our study demonstrated the potential of metabolomics to infer asthma-related biomarkers by the identification of potentially deregulated phospholipids that associate with asthma and asthma risk alleles.

KW - asthma

KW - genetics

KW - lipids

KW - metabolomics

UR - http://www.scopus.com/inward/record.url?scp=84876678696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876678696&partnerID=8YFLogxK

U2 - 10.1111/all.12110

DO - 10.1111/all.12110

M3 - Article

C2 - 23452035

AN - SCOPUS:84876678696

VL - 68

SP - 629

EP - 636

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 5

ER -